T-group (topology)
5014.1.1 iron-sulfur subunit (ISP) transmembrane anchor
Ligands and drugs
605
Member domains
290
with ligand contacts (≤ 4 Å)
47.9% of members
186
with DrugDomain annotations
30.7% of members
93
with a DrugBank compound
15.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5014.1.1 belongs to X-group 5014 iron-sulfur subunit (ISP) transmembrane anchor, which binds 4.8 ligand superclasses per 20 proteins, narrower than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04327 | PEE | Phosphatidylethanolamine | 53 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 25 |
| DB09114 | PCF | Colfosceril palmitate | 17 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 13 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 12 |
| DB09270 | U10 | Ubidecarenone | 8 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 4 |
| DB02144 | PIE | 1,2-diacyl-sn-glycero-3-phosphoinositol | 1 |
| DB02580 | PG6 | Pentaglyme | 1 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 1 |
| DB04799 | — | 6-Hydroxy-5-undecyl-4,7-benzothiazoledione | 1 |
| DB07401 | — | Azoxystrobin | 1 |
| DB07636 | — | 5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione | 1 |
| DB07763 | — | (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | 1 |
| DB07778 | — | (S)-famoxadone | 1 |
| DB08330 | — | METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE | 1 |
| DB08453 | — | 2-Nonyl-4-quinolinol 1-oxide | 1 |
| DB08690 | — | Ubiquinone Q2 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 96 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 75 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 53 |
| CDL | CARDIOLIPIN | 52 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 36 |
| FES | FE2/S2 (INORGANIC) CLUSTER | 26 |
| SQD | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL | 26 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 22 |
| PCF | 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE | 21 |
| 6PH | (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate | 18 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 16 |
| 7PH | (1R)-2-(dodecanoyloxy)-1-[(phosphonooxy)methyl]ethyl tetradecanoate | 14 |
| UMQ | UNDECYL-MALTOSIDE | 14 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 12 |
| U10 | UBIQUINONE-10 | 11 |
| PL9 | 2,3-DIMETHYL-5-(3,7,11,15,19,23,27,31,35-NONAMETHYL-2,6,10,14,18,22,26,30,34-HEXATRIACONTANONAENYL-2,5-CYCLOHEXADIENE-1,4-DIONE-2,3-DIMETHYL-5-SOLANESYL-1,4-BENZOQUINONE | 9 |
| UNL | Unknown ligand | 8 |
| PX4 | 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 7 |
| UQ6 | 5-(3,7,11,15,19,23-HEXAMETHYL-TETRACOSA-2,6,10,14,18,22-HEXAENYL)-2,3-DIMETHOXY-6-METHYL-BENZENE-1,4-DIOL | 7 |
| PGV | (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE | 6 |